Profound Medical Corp Market Cap ($247.94 Million)
Market Cap & Net Worth: Profound Medical Corp (PRN)
Profound Medical Corp market cap. Profound Medical Corp (TO:PRN) has a market capitalization of $247.94 Million (CA$342.75 Million) as of November 3, 2026. Listed on the TO stock exchange, this Canada-based company holds position #15479 globally and #458 in its home market, demonstrating a 20.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Profound Medical Corp's stock price CA$9.38 by its total outstanding shares 36540343 (36.54 Million). Also see Profound Medical Corp cash conversion from operations for how efficiently the company converts equity into cash flow.
Profound Medical Corp Market Cap History (2015–2026)
Profound Medical Corp market cap history from 2015 to 2026. Data shows growth from $21.15 Million to $247.94 Million (23.03% CAGR). Check PRN share price today for real-time trading data and today's change.
Profound Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Profound Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Profound Medical Corp to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
17.38x
Profound Medical Corp's market cap is 17.38 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $22.20 Million | $4.90 Million | -$14.97 Million | 4.53x | N/A |
| 2018 | $145.38 Million | $1.91 Million | -$15.24 Million | 76.09x | N/A |
| 2019 | $389.88 Million | $4.23 Million | -$20.19 Million | 92.14x | N/A |
| 2020 | $692.27 Million | $7.30 Million | -$21.62 Million | 94.78x | N/A |
| 2021 | $376.93 Million | $6.87 Million | -$30.70 Million | 54.84x | N/A |
| 2022 | $382.75 Million | $6.68 Million | -$28.67 Million | 57.29x | N/A |
| 2023 | $293.40 Million | $7.20 Million | -$28.57 Million | 40.76x | N/A |
| 2024 | $285.47 Million | $10.68 Million | -$27.82 Million | 26.73x | N/A |
| 2025 | $284.68 Million | $16.38 Million | -$43.32 Million | 17.38x | N/A |
Competitor Companies of PRN by Market Capitalization
Companies near Profound Medical Corp in the global market cap rankings as of November 3, 2026. Also see balance sheet size of Profound Medical Corp for a full breakdown of the balance sheet.
Key companies related to Profound Medical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Profound Medical Corp (2015–2026)
Market capitalization of Profound Medical Corp from 2015 to today. Between 2015 and today, Profound Medical Corp's market cap moved from $21.15 Million to $ 247.94 Million, with a yearly change of 23.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$247.94 Million | -12.91% |
| 2025 | CA$284.68 Million | -0.28% |
| 2024 | CA$285.47 Million | -2.70% |
| 2023 | CA$293.40 Million | -23.34% |
| 2022 | CA$382.75 Million | +1.54% |
| 2021 | CA$376.93 Million | -45.55% |
| 2020 | CA$692.27 Million | +77.56% |
| 2019 | CA$389.88 Million | +168.18% |
| 2018 | CA$145.38 Million | +554.76% |
| 2017 | CA$22.20 Million | -25.00% |
| 2016 | CA$29.60 Million | +40.00% |
| 2015 | CA$21.15 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Profound Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $247.94 Million USD |
| MoneyControl | $247.94 Million USD |
| MarketWatch | $247.94 Million USD |
| marketcap.company | $247.94 Million USD |
| Reuters | $247.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Profound Medical Corp
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedb… Read more